Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 533, doi. 10.1007/s40265-016-0546-7
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2016 AND VI 76 AND IP 5
Results: 9
1
2
Antipsychotic Management of Schizoaffective Disorder: A Review.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 589, doi. 10.1007/s40265-016-0551-x
- By:
- Publication type:
- Article
3
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 551, doi. 10.1007/s40265-016-0552-9
- By:
- Publication type:
- Article
4
Two-Drug Treatment Approaches in HIV: Finally Getting Somewhere?
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 523, doi. 10.1007/s40265-016-0553-8
- By:
- Publication type:
- Article
5
Elbasvir/Grazoprevir: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 617, doi. 10.1007/s40265-016-0558-3
- By:
- Publication type:
- Article
6
Comment on: 'Therapies to Preserve β-Cell Function in Type 1 Diabetes'.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 625, doi. 10.1007/s40265-016-0560-9
- By:
- Publication type:
- Article
7
Author's Reply to Dayal: 'Therapies to Preserve β-Cell Function in Type 1 Diabetes'.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 627, doi. 10.1007/s40265-016-0561-8
- By:
- Publication type:
- Article
8
Cobimetinib Plus Vemurafenib: A Review in BRAF Mutation-Positive Unresectable or Metastatic Melanoma.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 605, doi. 10.1007/s40265-016-0562-7
- By:
- Publication type:
- Article
9
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 567, doi. 10.1007/s40265-016-0545-8
- By:
- Publication type:
- Article